Related Experiment Video
Updated: Jul 5, 2026

07:15
Mitochondrial Respiration Quantification in Yeast Whole Cells
Published on: November 8, 2024
Resveratrol: one molecule, many targets.
1INSERM U870, Lyon South Hospital, IFR62, Oullins F-69600, France. luciano.pirola@sante.univ-lyon1.fr
IUBMB Life
|April 19, 2008
Summary
Resveratrol, a polyphenol, exhibits chemopreventive, cardioprotective, and metabolic benefits. This review outlines its diverse enzyme targets, suggesting its broad biological activities stem from multi-target interactions.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Resveratrol is a polyphenol found in plants with growing interest due to its health benefits.
- Key findings include chemopreventive, cardioprotective, and metabolic effects, extending lifespan in model organisms.
- These properties drive research into its molecular targets and mechanisms of action.
Purpose of the Study:
- To provide an overview of enzymes inhibited or activated by resveratrol.
- To explore the pharmacological relevance of resveratrol's interactions with various enzyme classes.
- To understand how resveratrol's multi-target activity contributes to its biological effects.
Main Methods:
- Literature review of studies identifying resveratrol's enzyme targets.
- Analysis of reported inhibitory and activatory effects of resveratrol on enzymes.
- Categorization of enzymes based on their interaction with resveratrol.
Main Results:
- Resveratrol interacts with a wide spectrum of enzymes, acting as both an inhibitor and activator.
- Effects are observed in both micromolar and nanomolar concentration ranges, with pharmacological relevance.
- Identified targets include enzymes involved in cancer, cardiovascular health, and metabolism.
Conclusions:
- Resveratrol possesses a broad range of molecular targets.
- Its diverse biological activities are likely mediated by simultaneous interactions with multiple enzymes.
- Further research into these interactions can elucidate resveratrol's therapeutic potential.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...